Effect of Brahmighrta in the management of Dementia

Pharmaceutical, Analytical and Clinical study Brahmighrta in the management of Dementia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047302

Enrollment

Registered

2022-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F192- Other psychoactive substance dependence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adults >40 years of age 2 Diagnosis of COPD at least for 1 year 3 At least one spirometry in the last year with a post-bronchodilator FEV1/FVC 4 Current or former smoker( >10 pack years)

Exclusion criteria

Exclusion criteria: 1. Any acute or chronic condition that would limit the ability of the patient to participate in the study. 2. Refusal to give informed consent

Design outcomes

Primary

Measure	Time frame
need to find out efficacious ayurveda medicine Brahmi ghrta for the management of dementia.Timepoint: The out come will be noted after 8 weeks	—

Secondary

Measure	Time frame
Estimating the components of Brahmi Ghrita by analytical studyTimepoint: 2 years	—

Countries

India

Contacts

Public ContactPrem Shankar Pandey

Institute of Medical Science, Banaras Hindu University

krcreddy@bhu.ac.in9415813533

Outcome results